Home

Current Issue

Archives

Guidelines for Authors

Classified Ads

Links

Search PubMed

Subscriptions

Subscriber Registration

Guidelines for Website Users

JRheum Update Service

Contact Info

Correction

Roldan R, Morote G, del Carmen Castro M, Miranda MD, Moreno JC, Collantes E. Efficacy of bosentan in treatment of unresponsive cutaneous ulceration in disabling pansclerotic morphea in children. J Rheumatol 2006;33:2538-40. In the Abstract and in the last paragraph of the first page of the report, the dose of bosentan is given as 31.25 mg qid; however, "qid" (4 times per day) is incorrect. The correct dosage is "qd" (once per day). We regret the error.